HomeDOSE • CNSX
add
Rapid Dose Therapeutics Corp
Previous close
$0.22
Day range
$0.22 - $0.23
Year range
$0.090 - $0.33
Market cap
28.22M CAD
Avg Volume
35.35K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Revenue | 515.92K | 46.08% |
Operating expense | 1.19M | 66.37% |
Net income | -1.10M | -50.50% |
Net profit margin | -213.15 | -3.03% |
Earnings per share | — | — |
EBITDA | -807.30K | -145.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.68K | -64.76% |
Total assets | 1.72M | -18.12% |
Total liabilities | 5.47M | -7.81% |
Total equity | -3.76M | — |
Shares outstanding | 124.64M | — |
Price to book | -7.33 | — |
Return on assets | -121.40% | — |
Return on capital | 227.89% | — |
Cash Flow
Net change in cash
| (CAD) | Aug 2024info | Y/Y change |
|---|---|---|
Net income | -1.10M | -50.50% |
Cash from operations | -261.31K | -42.62% |
Cash from investing | — | — |
Cash from financing | 219.93K | -37.84% |
Net change in cash | -41.38K | -124.25% |
Free cash flow | -71.20K | 83.91% |
About
Founded
2008
Headquarters
Website
